ASP Isotopes Inc. Common Stock (ASPI) - Net Assets
Based on the latest financial reports, ASP Isotopes Inc. Common Stock (ASPI) has net assets worth $274.79 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($572.05 Million) and total liabilities ($297.26 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ASPI PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $274.79 Million |
| % of Total Assets | 48.04% |
| Annual Growth Rate | 157.31% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 137.78 |
ASP Isotopes Inc. Common Stock - Net Assets Trend (2021–2025)
This chart illustrates how ASP Isotopes Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see how much is ASP Isotopes Inc. Common Stock worth.
Annual Net Assets for ASP Isotopes Inc. Common Stock (2021–2025)
The table below shows the annual net assets of ASP Isotopes Inc. Common Stock from 2021 to 2025. Also explore ASPI shareholders equity momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $262.90 Million | +413.81% |
| 2024-12-31 | $51.17 Million | +171.72% |
| 2023-12-31 | $18.83 Million | +91.81% |
| 2022-12-31 | $9.82 Million | +63.69% |
| 2021-12-31 | $6.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ASP Isotopes Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 22865707300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.12 Million | 0.55% |
| Other Comprehensive Income | $2.54 Million | 1.25% |
| Other Components | $431.76 Million | 211.49% |
| Total Equity | $204.15 Million | 100.00% |
ASP Isotopes Inc. Common Stock Competitors by Market Cap
The table below lists competitors of ASP Isotopes Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sierra Bancorp
NASDAQ:BSRR
|
$497.50 Million |
|
Risuntek Inc
SHE:002981
|
$497.57 Million |
|
Sanlux Co Ltd
SHE:002224
|
$497.67 Million |
|
Bewi Asa
OL:BEWI
|
$497.78 Million |
|
Anhui Xinli Finance Co Ltd
SHG:600318
|
$497.44 Million |
|
Bénéteau S.A.
PA:BEN
|
$497.40 Million |
|
Jiangsu Lianfa Textile Co Ltd
SHE:002394
|
$497.36 Million |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
$497.27 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ASP Isotopes Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 47,898,492 to 204,151,000, a change of 156,252,508 (326.2%).
- Net loss of 175,092,000 reduced equity.
- New share issuances of 320,304,000 increased equity.
- Other comprehensive income increased equity by 4,706,313.
- Other factors increased equity by 6,334,195.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-175.09 Million | -85.77% |
| Share Issuances | $320.30 Million | +156.9% |
| Other Comprehensive Income | $4.71 Million | +2.31% |
| Other Changes | $6.33 Million | +3.1% |
| Total Change | $- | 326.22% |
Book Value vs Market Value Analysis
This analysis compares ASP Isotopes Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.32x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 18.59x to 1.32x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $0.17 | $3.25 | x |
| 2022-12-31 | $0.27 | $3.25 | x |
| 2023-12-31 | $0.49 | $3.25 | x |
| 2024-12-31 | $0.86 | $3.25 | x |
| 2025-12-31 | $2.46 | $3.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ASP Isotopes Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -85.77%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -734.17%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 2.51x
- Recent ROE (-85.77%) is below the historical average (-69.41%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -43.48% | 0.00% | 0.00x | 1.19x | $-3.21 Million |
| 2022 | -50.37% | 0.00% | 0.00x | 1.27x | $-5.93 Million |
| 2023 | -99.94% | -3761.03% | 0.01x | 1.85x | $-17.92 Million |
| 2024 | -67.51% | -780.26% | 0.04x | 1.97x | $-37.12 Million |
| 2025 | -85.77% | -734.17% | 0.05x | 2.51x | $-195.51 Million |
Industry Comparison
This section compares ASP Isotopes Inc. Common Stock's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $1,564,870,667
- Average return on equity (ROE) among peers: 3.63%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ASP Isotopes Inc. Common Stock (ASPI) | $274.79 Million | -43.48% | 1.08x | $497.49 Million |
| Albemarle Corp (ALB) | $3.94 Billion | 16.33% | 1.07x | $13.57 Billion |
| Alto Ingredients Inc (ALTO) | $296.24 Million | -5.10% | 0.61x | $311.82 Million |
| Aemetis Inc (AMTX) | $-263.93 Million | 0.00% | 0.00x | $127.74 Million |
| Air Products and Chemicals Inc (APD) | $5.17 Billion | 17.61% | 1.43x | $62.29 Billion |
| Ashland Global Holdings Inc (ASH) | $2.20 Billion | 13.18% | 1.92x | $3.20 Billion |
| Aspen Aerogels Inc (ASPN) | $123.72 Million | -53.61% | 0.17x | $407.47 Million |
| Avient Corp (AVNT) | $978.50 Million | 24.92% | 1.99x | $3.38 Billion |
| Axalta Coating Systems Ltd (AXTA) | $1.41 Billion | 2.61% | 3.85x | $6.23 Billion |
| Balchem Corporation (BCPC) | $232.01 Million | 16.71% | 0.17x | $5.17 Billion |
About ASP Isotopes Inc. Common Stock
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay lo… Read more